![](/img/cover-not-exists.png)
Misclassifying the indications for prostate-specific antigen testing may bias case–control studies of the efficacy of prostate cancer screening
Richard M. Hoffman, Meg L. Adams-Cameron, Glen H. MurataVolume:
57
Year:
2004
Language:
english
DOI:
10.1016/j.jclinepi.2004.02.011
File:
PDF, 160 KB
english, 2004